Sam David’s story begins in Thiruvananthapuram, where he built a reputation as a project manager who thrived on what he proudly called his ‘high energy’ lifestyle. At 52, he believed that his occasional headaches and blurred vision were simply the price of long hours spent in front of a computer screen. When he felt a tightness in his chest after climbing stairs, he dismissed it as the result of pandemic weight gain. Years earlier, an insurance physical had flagged his blood pressure as borderline high, but because he felt strong and capable, he treated the diagnosis as a technicality rather than a warning. He tried medication briefly, then abandoned it, convinced that feeling “fine” most days meant he was safe. Deadlines mattered more than doctor visits, and he assumed that if something was truly wrong, his body would make it unmistakably clear.
That illusion shattered one Tuesday morning during a routine briefing. In mid sentence, David found himself unable to recall the words he needed. What he brushed off as a momentary lapse was in fact the culmination of years of untreated hypertension. By the time he reached the hospital, his BP had climbed to 190/110 mmHg. The diagnosis was a transient ischemic attack (mini-stroke), a stark reminder that his supposed vitality was masking a body under relentless strain. His refusal to take medication had left his organs exposed to the constant pounding of uncontrolled blood flow.
Recovery forced him to confront reality. He began adhering to daily medication, cut back on sodium, and introduced moderate exercise into his routine. His journey illustrates that hypertension is not a flaw of character or an unavoidable consequence of age, but a medical condition requiring vigilance and partnership with healthcare providers. His experience is far from unique; it is the human face of a silent epidemic that often begins quietly and ends in sudden, life altering events.
Hypertension, often called the “silent killer,” remains one of India’s most pressing health challenges. It drives heart disease, stroke, kidney failure, and even cognitive decline. Despite decades of awareness campaigns, poorly managed blood pressure continues to burden the healthcare system.
The pattern is familiar – diagnosis, brief compliance, lapse, and crisis. The condition is easy to detect but notoriously difficult to control. Doctors see the consequences daily and point to a mix of medical, behavioural and systemic factors behind the gap between diagnosis and control. “We prescribe four to five drugs. They don’t follow it,” says Dr Mathew Iype, HOD of cardiology at Government Medical College, Thiruvananthapuram, capturing the frustration that many doctors feel when patients abandon treatment once symptoms subside.
Non-adherence is rarely a single choice – it is shaped by side effects, cost, cultural beliefs, and the false reassurance of feeling well. Patients like David stop medication because the immediate discomfort is gone, unaware that the silent damage continues.
The damage caused by sustained high blood pressure is cumulative and far reaching. Constant pressure thickens and stiffens vessel walls, forcing the heart to work harder. Over time, this increases the risk of heart attacks and heart failure. Narrowed arteries restrict blood flow to the limbs, leading to peripheral arterial disease, while in the brain they cause ischemia, strokes, and micro bleeds that erode memory and cognition.
The kidneys, with their delicate filtering systems, are especially vulnerable, and chronic hypertension is a leading cause of renal failure. As Dr Harikrishnan S of Sree Chitra Tirunal Institute notes, hypertension rarely announces itself with symptoms, it is often discovered only after irreversible damage has occurred.
Yet the clinical picture is rarely as simple as “take a pill and be cured.” Modern hypertension management often requires combination therapy, lifestyle changes, and careful tailoring of drugs to the individual. Physicians must ask whether a patient is truly taking their medicines as prescribed and whether the chosen drugs are the best fit for that person’s age, heart rate, comorbidities and tolerance.
“Drug choice must be individualised,” Dr Iype explains, noting that some medications are more effective in younger patients than older ones, and that side effect profiles matter – certain drugs can precipitate asthma, while pregnancy demands a different set of safe options. When blood pressure remains uncontrolled despite the use of four classes of drugs — one of which should be a diuretic, it becomes a case for uncontrolled hypertension.
The doctors must also look beyond adherence and consider secondary causes such as adrenal tumours, renal artery stenosis, or glomerulonephritis. Identifying these can transform a patient’s prognosis. This is particularly important in younger patients, where hypertension often stems from treatable conditions like congenital narrowing of the aorta or blockages in renal vessels. Because many of these causes can be resolved with targeted treatment, ruling them out is essential, said Dr Harikrishnan.
David now takes three medications daily, and has changed his diet. His life is quieter and more measured, but he is alive and aware in a way he was not before. His story is a reminder that hypertension is not an abstract statistic but a personal risk that can be managed with vigilance, the right drugs, and a health system that supports patients long after the prescription is written.